Filana Therapeutics Inc. – Filings and Transcripts

NASDAQ: FLNA
Share price (4/6/26): $1.68
Market cap (4/6/26): $81.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus for primary offering

Shelf registration

Removal from listing

Prospectus for primary offering

Registration of securities on exchange

Ownership Filter

Anderson Robert Eugene Jr

Bir Dawn Carter

Bir Dawn Carter

News Filter

Reports Fourth Quarter and Full Year 2025 Financial Results

Cassava Sciences Announces Name Change to Filana Therapeutics, Inc

Cassava Announces Closure of U.S. Department of Justice Investigation

Material Definitive Agreement

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission

Letter from the SEC